MALP-2 (Helmholtz Zentrum fur Infektionsforschung)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMALP-2 (Helmholtz Zentrum fur Infektionsforschung)
Drug Alias NameTLR agonist (Helmholtz Zentrum fur Infektionsforschung/Ascenion)MALP-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionToll-like receptor agonists
TargetsToll-like receptor
Therapy Area/IndicationsNeoplasmsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelmholtz Zentrum fur Infektionsforschung GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelmholtz Zentrum fur Infektionsforschung GmbHAscenion
Active IndicationsN/A
Inactive IndicationsNeoplasmsSepsis

Other Information

ATC CodeN/A
Related LinksN/A